Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Surmodics, Inc. logo — To improve the detection and treatment of disease.

Surmodics, Inc.

To improve the detection and treatment of disease.

Founded 1979 United States Eden Prairie, United States 304 employees Post-IPO Debt Total: $125.00M Biotechnology, Health Care +2

General Information

Company Name Surmodics, Inc.
Founded Year 1979
Location United States Eden Prairie, United States
Founders / Decision Makers
Team member
Employees 304
Industries Biotechnology, Health Care, Manufacturing +1
Funding Stage Post-IPO Debt
Social

BounceWatch is an independent company data service, not affiliated with Surmodics, Inc.. To contact Surmodics, Inc., visit surmodics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Surmodics, Inc. compare?

A PDF of Surmodics, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Surmodics, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Surmodics, Inc.

Surmodics, Inc., founded in 1979, is a leader in Biotechnology and Medical Devices, headquartered in the United States. The company stands out with its focus on surface modification technologies for intravascular medical devices, as well as the production of chemical components for in vitro diagnostic (IVD) immunoassay tests and microarrays.

Operating under the slogan, "To improve the detection and treatment of disease.", Surmodics is dedicated to addressing unmet clinical needs with highly differentiated medical devices. This commitment positions Surmodics for sustained growth and innovation within the Health Care and Manufacturing sectors.

The company's financial robustness is underscored by a recent $125.00M post-IPO debt investment, finalized on 17 October 2022. This investment came from MidCap Financial, highlighting investor confidence in Surmodics' strategic direction and future potential.

Business keywords: Intravascular Medical Devices, Surface Modification Technologies, Chemical Components, In Vitro Diagnostics, IVD Immunoassay Tests, Microarrays, Clinical Needs, Differentiated Medical Devices, Engineered Products, Diagnostic Technologies, Innovation, Clinical Research

Services & Products

Development and manufacturing of interventional medical devices
Production of medical device and performance coatings
Provision of chemical components for in vitro diagnostics
Contract development and scalable manufacturing solutions

Target Customers

Physicians specializing in interventional procedures Healthcare providers using thrombectomy systems Medical device manufacturers Diagnostic testing companies

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt $125.00M 1
MidCap Financial
MidCap Financial
17 Oct 2022

Surmodics, Inc. Alternatives & Competitors

View All Alternatives
Surmodics, Inc. vs
Fujirebio
Fujirebio Japan

A proven pioneer and partner to the diagnostics industry.

Venture round
726 employees
Biotechnology, Health Care
Compare Surmodics, Inc. vs Fujirebio
Surmodics, Inc. vs
General Biologicals Corp. (GBC)
General Biologicals Corp. (GBC) Taiwan

An innovated IVD manufacturer making quality products for everyone.

20 employees
Health Care, Manufacturing
Surmodics, Inc. vs
RealMind Biotech Asia
RealMind Biotech Asia China

For Better Diagnosis

Seed
6 employees
Biotechnology, Health Care
Compare Surmodics, Inc. vs RealMind Biotech Asia
View all alternatives

FAQ About Surmodics, Inc.

To improve the detection and treatment of disease.
Surmodics, Inc. was founded in 1979.
Surmodics, Inc. is headquartered in Eden Prairie, United States.
Surmodics, Inc. operates in Biotechnology, Health Care, Manufacturing and Medical Devices. Its work centres on Intravascular Medical Devices, Surface Modification Technologies, Chemical Components and In Vitro Diagnostics. Its customers include Physicians specializing in interventional procedures, Healthcare providers using thrombectomy systems and Medical device manufacturers.
Surmodics, Inc. has approximately 304 employees.
Surmodics, Inc. has completed 1 funding round, raising a total of $125.00M. The latest funding stage is Post-IPO Debt.
Surmodics, Inc. offers: Development and manufacturing of interventional medical devices, Production of medical device and performance coatings, Provision of chemical components for in vitro diagnostics, Contract development and scalable manufacturing solutions.
Top alternatives and competitors to Surmodics, Inc. include Fujirebio, General Biologicals Corp. (GBC), RealMind Biotech Asia, Verify Diagnostics, Quidel. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Surmodics, Inc. and Fujirebio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Surmodics, Inc., https://bouncewatch.com/company/surmodics-inc, updated 23 October 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout